Overview

Influence of Drug-drug Interactions on the Pharmacokinetics (PK) of Voriconazole

Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
To evaluate the drug-drug interaction between rifampicin and voriconazole according to CYP2C19 genotype quantitatively following a single oral administration of 200 mg voriconazole
Phase:
Phase 1
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
Voriconazole